Locations
United States · Cambridge, MA, USA · North America · Cambridge, MA, USA
industry
Biotechnology · DeepTech · Health
Size
201-1000 employees
Stage
Other
founded in
1993
bluebird bio is a clinical-stage biotechnology company that develops gene therapies for severe genetic and rare diseases. The company's gene therapy procedures aim to genetically modify a patient's cells to fundamentally correct or address the genetic basis underlying a disease. Bluebird's revenue is derived from collaboration arrangements, research fees, license fees, and grant revenue. The company works with industry peers, strategic partners, and nonprofit organizations for the development and commercialization of its product candidates.
Something looks off?On-site & Remote